Troponin Measurements during Drug Development – Considerations for Monitoring and Management of Potential Cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, Duke Clinical Research Institute, and the US Food and Drug Administration

Read the paper here: Troponin Measurements during Drug Development – Considerations for Monitoring and Management of Potential Cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, Duke Clinical Research Institute, and the US Food and Drug Administration

Newby K, et al. Troponin Measurements during Drug Development – Considerations for Monitoring and Management of Potential Cardiotoxicity. Am Heart J. 2011; 162(1):64-73